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esponsibility of Xi'aAbstract A simple modiﬁcation converts an electrospray ion source to an ambient-pressure helium
plasma ionization source without the need of additional expensive hardware. Peaks for active ingredients
were observed in the spectra recorded from intact pharmaceutical tablets placed in this source. A ﬂow of
heated nitrogen was used to thermally desorb analytes to gas phase. The desorption temperatures were
sometimes as low as 50 1C. For example, negative-ion spectra recorded from an aspirin tablet showed
peaks at m/z 137 (salicylate anion) and 179 (acetylsalicylate anion) which were absent in the background
spectra. The overall ion intensity increased as the desorption gas temperature was elevated. Within the
same acquisition experiment, both positive- and negative-ion signals for acetaminophen were recorded
from volatiles emanating from Tylenol tablets by switching the polarity of the capillary back and forth.
Moreover, different preparations of acetaminophen tablets could be distinguished by their ion-intensity
thermograms.
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Traditional techniques for analysis of pharmaceutical formulations,
such as chromatographic and excitation spectroscopic methods, are
time-consuming and need speciﬁc sample handling procedures.
In contrast, mass-spectrometry-based techniques are considered more
efﬁcient. With the introduction of the new approach of desorptionvier B.V. All rights reserved.
Detection of ingredients in intact tablets by HePI-MS 167electrospray ionization mass spectrometry (DESI-MS) [1], the
sampling methods focused on ambient ionization techniques have
received considerable attention [2,3]. DESI, which uses a spray of
charged solvent droplets from an electrospray ion source, relies
upon the formation of secondary ions from analytes present in a
sample. By this procedure, active ingredients in drug formula-
tions and intact pharmaceutical tablets have been detected directly
[4–8]. However, for more efﬁcient sample desorption the tablets
should be broken into pieces [9,10]. Additionally, although rapid
switching between positive- and negative-ion generating modes is
possible with DESI, the chemistry of the spray solution should
be modiﬁed for each mode to optimize signal intensity [10].
Furthermore, the use of a solvent spray sometimes interferes with
the integrity of the sample. Moreover, DESI is well-known to form
cationic metal adducts, in addition to the desired protonated
molecules [11].
Another commonly used method for direct determination of
pharmaceutical drug formulations is direct-analysis-in-real-time
mass spectrometry (DART-MS). DART is able to detect
principal compounds directly without the need of solvents or
prior sample preparation [12]. For DART ionization, gaseous
metastable atoms or molecules produced from a glow discharge,
together with neutral molecules, are heated and directed toward a
sample held between the ion source outlet and the mass
spectrometer interface inlet [12]. It is known that sample
orientation and sample proximity to the ion source inlet strongly
inﬂuence the signal variance; inconsistent sample positioning
results in variable heating due to differences in thermal gradients
[13]. In contrast to DART, which is a corona-to-glow discharge,
the ﬂowing atmospheric-pressure afterglow (FAPA) source
described by Shelley et al. employs a corona-to-glow transition
discharge. For FAPA, helium or some other discharge gas is
passed over a pin cathode [14]. Both methods generate some-
what similar mass spectra. One drawback of helium-mediated
ion sources, such as DART and FAPA, is that they require
expensive hardware modiﬁcations and consume excessive
amounts of helium [15].
In order to develop a high-throughput and more economical
procedure, particularly for switching between positive- and negative-
ion generating modes and for the analysis of intact tablets, we
investigated the applicability of the recently described helium-plasma
ionization mass spectrometric method [15–17] to the direct analysis
of pharmaceutical preparations. Results obtained from several over-
the-counter and prescription pharmaceutical tablets and capsules are
reported here.2. Experimental
2.1. Materials
Advils (Wyeth, Madison NJ; Ibuprofen: 200 mg), Aspirin
(Wakefern, Elizabeth NJ; 325 mg), Claritins (Schering-Plough,
Memphis TN; Loratadine: 10 mg), Regular Strength Tylenols
(McNeil, Fort Washington PA; Acetaminophen: 325 mg), Extra
Strength Tylenols (McNeil, Fort Washington PA; Acetamino-
phen: 500 mg), Children's Tylenols Meltawayss (McNeil, Fort
Washington PA; Acetaminophen: 80 mg), Paracetamol (Bufferin
Cold) Daytime formulation (Sino-American Shanghai Squibb
Pharmaceuticals Ltd, Shanghai CN; Acetaminophen: 500 mg,
Pseudoephedrine HCl: 30 mg, Dextromethorphan HBr: 15 mg),
Paracetamol (Bufferin Cold) Nighttime formulation (Sino-American Shanghai Squibb Pharmaceuticals Ltd, Shanghai CN;
Acetaminophen: 500 mg, Pseudoephedrine HCl: 30 mg, Dextro-
methorphan HBr: 15 mg, Chlorpheniramine Maleate: 2 mg),
CVSs Pharmacy Severe Head Congestion Cold Relief Daytime
formulation (CVSs Pharmacy, Woonsocket RI; Acetaminophen:
325 mg, Dextromethorphan HBr: 10 mg, Phenylephrine HCl:
5 mg, Guaifenesin: 200 mg), CVSs Pharmacy Multi-Symptom
Cold Relief Nighttime (CVS Pharmacy, Woonsocket RI; Acet-
aminophen: 325 mg, Chlorpheniramine Maleate: 2 mg, Dextro-
methorphan HBr: 10 mg, Phenylephrine HCl: 5 mg), Dramamines
(Prestige Brands, Tarrytown NY; Dimenhydrinate: 50 mg), and
Bonines (Insight Pharmaceuticals, Trevose PA; Meclozine HCl:
25 mg) were obtained without prescription from a pharmacy.
Simvastatin (Merck, Whitehouse Station NJ; 20 mg), Verapamil
(Mylan, Canonsburg PA; 120 mg), and Clindamycin HCl (Teva, North
Wales PA; 300 mg) were obtained by prescription.2.2. Instrumentation and procedures
A commercially available Z-electrospray ion source of a Waters
Micromass Quattro Ultima mass spectrometer was modiﬁed into
a helium-plasma ionization source as described previously
[14–16]. In brief, a stream (25–30 mL/min) of high-purity helium
(99.999%, Airgas, Radnor, PA) was supplied through the sample
delivery metal capillary held at a high voltage (typically,
3 kV). The capillary was placed at an angle of 901, about
10 mm away from the outer cone oriﬁce. Mass spectra were
recorded upon exposure of each tablet to the helium plasma
generated in this way, at the tip of the metal capillary (Fig. 1).
Each tablet was held in a ﬁxed position with a pair of tweezers,
and exposed to the helium plasma ionization source. The results
were processed using the MassLynx software (version 4.0). The
ion source was cleaned by wiping with a methanol-soaked cotton
swab before each new sample was introduced. The cone voltage
was held between 10 and 20 V. The source temperature was
maintained at 100 1C. Nitrogen was used as the desolvation gas
(Gas 2, Fig. 1) at a ﬂow rate of about 3.5 L/min. The heater in the
desolvation gas line was used to increase the temperature of the
nitrogen desolvation gas (in other words, the desolvation gas of
the electrospray ionization source was used as the thermal
desorption agent). Each tablet was analyzed at seven different
desorption temperatures: 50 1C, 100 1C, 150 1C, 200 1C, 250 1C,
300 1C, and 350 1C. Simvastatin and other high-molecular-
weight analytes were investigated at higher temperatures such
as 400 1C, 450 1C, and 500 1C. Background spectra were acquired
at each desolvation-gas temperature and subtracted from the raw
spectra. Mass spectra were recorded under both positive- and
negative-ion generating modes. For tandem mass spectrometric
experiments, the pressure of argon used as the collision gas was
adjusted to attenuate the ion beam by 50%.
For thermograms, total ion intensity proﬁles (m/z 15–500) were
recorded under negative-ion generating conditions from volatiles
emanating from two types of preparations containing acetamino-
phen. The two types of preparations used were Regular Strength
Tylenols and CVSs Pharmacy Severe Head Congestion Cold
Relief Daytime formulation. Initially, background spectra were
recorded at 50 1C for the ﬁrst 2 min. The tablet was then
introduced into the ion source at 50 1C, and the temperature was
increased by 50 1C every 2 min to reach a ﬁnal temperature of
300 1C at 12 min.
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Fig. 1 A schematic diagram that illustrates an electrospray ionization source modiﬁed to function as a helium plasma ionization source (HePI)
(Gas 1 supply was not used; Gas 2 was nitrogen). The tip of the capillary is about 10 mm from the cone oriﬁce inlet of the mass analyzer.
A.B. Attygalle et al.1683. Results and discussion
The formation of a zone of helium plasma at the tip of the capillary
was noted when a low ﬂow of helium gas was passed through the
tube of the modiﬁed electrospray source while a high potential was
being applied [15]. In this way, any electrospray ionization source
can be converted to a helium-plasma ionization source without the
need for any additional hardware. Apparently, the use of helium as
the coaxial nebulizing gas has been avoided by the pioneers of the
electrospray technique because the facile formation of a low-
voltage plasma caused complications with the electrospray ioniza-
tion process. We also found that the glow discharge obtained by
using helium as the coaxial nebulizer gas is erratic. However, we
discovered that a more stable plasma can be obtained if helium is
passed through the capillary. The spectra recorded from ions
generated in this way from similar samples were comparable to
those obtained by other ambient pressure ionization mass spectro-
metric methods such as DART-MS. For DART, the potential is
applied to an external needle exposed to a ﬂow of 1.5–3 L of
helium per minute. In contrast, our method consumes only about
20–30 mL of helium per minute.
The excited helium atoms in the plasma are in the so-called
“metastable” state (23S1) and carry about 19.8 eV of energy. Upon
interactions with ambient molecules (or any analyte molecules)
with an ionization potential lower than the energy carried by
excited helium atoms, a process called Penning ionization takes
place. Ionized molecules generated in this way then transfer charge
to other analyte molecules by secondary charge-exchange reac-
tions [15].
The amount of volatile molecules emanating from pharmaceu-
tical preparations at ambient, or slightly above ambient, tempera-
tures was expected to be relatively low. However, prominent
peaks were observed when mass spectra were recorded after
intact pharmaceutical tablets were exposed to a HePI source.For example, the spectra recorded under negative-ion generating
conditions from an intact Aspirin tablet showed sample-speciﬁc
peaks at m/z 137 and 179. The generation of these ions in the
source was evident even at desorption temperatures as low as
50 1C (Fig. 2B). These peaks were absent in the spectra recorded
from background ions (Fig. 2A). Other spectra shown in Fig. 2
were recorded from volatiles emanating from an unbroken aspirin
tablet at different desorption temperatures (50–350 1C, Fig. 2B–H).
The peaks at m/z 60 (CO3
d), 61 (HCO3 ), 77 (CO2 OOH),
and 212 represent background ions generated by the ionization of
ambient gases and source impurities [12]. The peaks at m/z 137
(salicylate anion) and 179 (acetylsalicylate anion) appeared only
after an aspirin tablet was introduced to the source (Fig. 2B).
As the temperature of the thermal desorption gas was increased,
a gradual increase of the overall ion intensity was recorded.
At higher temperatures, the intensities of sample peaks were
so overwhelming that the background peaks were no longer
signiﬁcant (Fig. 2H). Moreover, at about 350 1C, a peak appeared
at m/z 275 for the salicylic acid dimer. The identities of m/z 179
and m/z 137 ions were conﬁrmed by tandem mass spectrometric
experiments (Supplementary Fig. 1).
Fig. 3 depicts signal intensity proﬁles recorded after placing an
intact Extra Strength Tylenol tablet in the helium plasma ioniza-
tion source. The desorption gas temperature was held at 300 1C.
Initially, signals were recorded under positive-ion generating
conditions (Fig. 3A). After 2 min, the capillary voltage was
switched to negative polarity, and negative-ion spectra were
recorded for 2 min (Fig. 3B). The switching between the positive
and negative modes was repeated every 2 min (Fig. 3C and D).
In this way, mass spectral peaks for the active ingredient (acetami-
nophen; nominal mass 151) were observed as a protonated species
(m/z 152) or a deprotonated species (m/z 150) in consecutive
positive- and negative-ion generating modes within one experiment.
The results demonstrated the versatility of the helium plasma
Fig. 2 Mass spectra recorded under negative-ion generating HePI-
MS conditions from ambient background volatiles (A), and those
emanating from an Aspirin tablet exposed to “desolvation gas” heated
to different temperatures (50–350 1C) (B–H). The spectra are shown
without any background subtraction. Peaks at m/z 60, 61, 77, and 212
represent background ions present in the source.
Detection of ingredients in intact tablets by HePI-MS 169ionization procedure for rapid switching between positive- and
negative-ion generating modes. Obtaining both positive and
negative spectra is vital for complete characterization of ingre-
dients because certain compounds selectively ionize in one mode.
For example, peaks for the minor components dextromethorphan
[(MþH)þ, m/z 272] and chlorophenamine [(MþH)þ, m/z 275
and 277] in CVSs Pharmacy Multi-Symptom Cold Relief caplets are
observed only in the positive ion mode (Supplementary Fig. 2A),
whereas the phenolic compound phenylephrine [(MH) , m/z 166]
is detected under the negative mode (Supplementary Fig. 2B).
Although rapid polarity switching is also possible under
desorption electrospray ionization (DESI) conditions, for optimal
ion generation the chemistry of the spray solvent should be varied
between modes [10]. Moreover, ESI-related desorption techniques
charge analytes not only by protonation but also by cationization
with metal ions, which most analytical chemists consider a
nuisance [18]. Chan et al. described a procedure to evade metal
adduct formation by using toluene as the spray solvent [19].
On the other hand, the HePI procedure described here is not only
suitable for rapid polarity switching within one experiment, but it
also avoids complexities due to the formation of metal adducts.Results similar to those obtained from Extra Strength Tylenol
tablets (Fig. 3) were obtained from Paracetamol Daytime tablets
(Supplementary Fig. 3). Both Tylenol and Paracetamol contain
acetaminophen as the active pharmaceutical ingredient, and its identity
was conﬁrmed by tandem mass spectrometry (Supplementary
Fig. 4A and B). However, the spectra recorded from Paracetamol
showed several additional peaks (Supplementary Figs. 3 and 5).
For example, the peak at m/z 166 in the negative-ion spectra,
and that at m/z 168 in the positive-ion spectra represented an
additional ingredient of nominal mass 167, which was identiﬁed
as phenylephrine by its product-ion spectrum recorded by tandem
mass spectrometry (Supplementary Fig. 4C).
Although proﬁle data obtained from Paracetamol Night-
time tablets (Supplementary Figs. 6 and 7), were very similar to
those obtained from Paracetamol Daytime tablets (Supplementary
Figs. 3 and 5), it was noted that the intensities of acetaminophen-
related peaks (for example m/z 150 and 301 in the negative mode)
relative to the background peaks (m/z 60 and 77) increased more
rapidly for Paracetamol Daytime tablets (Supplementary Fig. 3)
than those for Paracetamol Nighttime tablets (Supplementary
Fig. 6) as the temperature of the desorption gas was increased.
Many acetaminophen preparations have additional ingredients includ-
ing pharmacologically inactive excipients (Supplementary Fig. 8).
In order to ﬁnd out the diagnostic value of the mass spectral
proﬁles obtained from total volatiles at different thermal deso-
rption temperatures, spectra were recorded from two different
preparations of acetaminophen tablets. At ﬁrst, background spectra
were recorded at 50 1C for 2 min, then a tablet was introduced into
the ion source, and after an initial isothermal period of 2 min the
desorption temperature was increased every 2 min by 50 1C. Total-
ion spectral proﬁles obtained for the m/z 15–500 range from
volatile compounds emanating from intact Regular Strength
Tylenol and Paracetamol Daytime tablets are depicted in Fig. 4.
Both these tablets are different preparations of acetaminophen.
However, the former is an uncoated tablet whereas the latter is
coated. A comparison of the intensity curves obtained from three
determinations for each tablet showed that the proﬁles were speciﬁc
and reproducible for each preparation (Fig. 4). For example, the total-
ion signals recorded from the emanating volatiles from the uncoated
Regular Strength Tylenol tablets reached the maximum (“saturation” at
1 1010 arbitrary units) at 250 1C (upper three proﬁles; Fig. 4) whereas
the coated Paracetamol Daytime tablets required a temperature of
300 1C for saturation (lower three proﬁles; Fig. 4). Presumably, the
differences observed are due to the presence of a thicker outer coating
in the coated Paracetamol Daytime tablets.
The applicability of the thermal desorption procedure to
characterize volatiles emanating from pharmaceutical preparations
was further tested with Advils, Claritins, Simvastatin, Drama-
mines, Bonines, Verapamil, and Clindamycin tablets. The
spectra acquired under negative-ion generating mode from Advil
tablets showed a peak at m/z 205 ion for the deprotonated active
ingredient ibuprofen (Supplementary Fig. 9). A product-ion
spectrum of m/z 205 conﬁrmed that it is a carboxylic acid
(Supplementary Fig. 10). At higher temperatures (4350 1C), three
new peaks appeared at m/z 325, 383, and 397 in the spectra
recorded from Advil tablets. Collision-induced dissociation of ions
of m/z 325 and 383 indicated that these ions are related to
ibuprofen (Supplementary Fig. 11).
The active ingredient in Claritin tablets is loratadine. Relatively
high desorption gas temperatures were required for the thermal
desorption of loratadine from Claritin tablets. The ﬁrst signals for
protonated loratadine appeared only at about 200 1C. At 350 1C,
Fig. 3 Total ion intensity proﬁles (m/z 15–500) recorded from volatiles emanating from an Extra Strength Tylenol tablet exposed to “desolvation
gas” heated to 300 1C. Spectra were recorded under positive-ion generating conditions for 2 min (A), and then under negative-ion generating mode
for the next 2 min (B). This rapid switching procedure was repeated at 2-min intervals (C and D). Spectra shown in insets were obtained by
co-adding all spectra for each segment.
Fig. 4 Total ion intensity proﬁles (m/z 15–500) recorded under
negative-ion generating conditions from volatiles emanating from two
different preparations of acetaminophen tablets exposed to hot
“desolvation gas.” The two types of tablets exposed were regular
strength (upper traces), and cold-relief daytime (lower traces). Back-
ground spectra were recorded at 50 1C for the ﬁrst 2 min. The tablet
was then introduced into the ion source at 50 1C, and the temperature
was increased by 50 1C every 2 min to reach a ﬁnal temperature of
300 1C at 12 min.
A.B. Attygalle et al.170a well-deﬁned peak cluster with the characteristic intensity proﬁles
for the different isotopologs of protonated loratadine was visible
(Supplementary Fig. 12). The identity of loratadine was conﬁrmed
by tandem mass spectrometry (Supplementary Fig. 13). The spectrarecorded from both Dramamine and Meclozine tablets showed intense
peaks for the active ingredients (Supplementary Figs. 14 and 15,
respectively). To demonstrate the high-throughput applications of the
method described, we exposed four different pharmaceutical tablets
(simvastatin, verapamil, meclozine, and loratadine), one at a time,
within a span of 5 min (Fig. 5). Each tablet was exposed for
approximately 30 s. The total ion intensity sharply increased at each
tablet insertion and immediately decreased to background level once
the tablet was removed from the source. For our experiments, tablets
were introduced manually. Automation should decrease the per tablet
analysis time to less than 1 min.
By the technique described, peaks were recorded even from active
ingredients with molecular weights above 400. For example, the
positive-ion spectrum recorded from simvastatin tablets showed a peak
at m/z 419 for the protonated species (Supplementary Fig. 16). The
signals started to appear only at about 350 1C because simvastatin is a
relatively large molecule. At the same high temperature, a peak was
observed at m/z 455 for the active ingredient of Verapamil tablets
(Supplementary Fig. 17), and at m/z 425 for that of Clindamycin tablets
(Supplementary Fig. 18).4. Conclusions
We have described a high-throughput procedure for the direct
analysis of intact pharmaceutical tablets by an ambient-pressure mass
spectrometric technique. Compared to the widely deployed DESI-MS
procedures, which often generate sodium and other cationic adducts
(and anionic adducts under negative-ion generating conditions), our
helium plasma ionization procedure does not generate any metal
adducts. For rapid switching between positive- and negative-ion
Fig. 5 The total ion intensity proﬁle (m/z 25-500) recorded from volatiles
emanating from simvastatin (0.75–1.25 min), verapamil (2.00–2.50 min),
meclozine (3.25–3.50 min), and loratadine (4.00–4.50 min) tablets exposed
to “desolvation gas” heated to 350 1C under positive-ion generating
conditions (A), and the extracted ion intensity proﬁles for simvastatin
([MþH]þ, m/z 419) (B), verapamil ([MþH]þ, m/z 455) (C), meclozine
([MþH]þ, m/z 391) (D), and loratadine ([MþH]þ, m/z 383) (E).
Detection of ingredients in intact tablets by HePI-MS 171generating modes, DESI-MS is not very practical because the
chemistry of the spray solution must be changed and optimized for
each mode. In the solventless HePI-MS procedure, the polarity can be
switched from one acquisition mode to the other without the need for
reoptimization. Moreover, the HePI-MS procedure consumes much
less helium than that required for DART or FAPA-MS. The results
reported here from several over-the-counter and prescription pharma-
ceutical preparations demonstrate the potential of the helium plasma
ionization procedure for developing high-throughput protocols for drug
analysis. Furthermore, peaks for sodium and other metal adducts were
not observed in the spectra recorded under the positive-ion-generatingmode. This is a key advantage of HePI over most spray methods
because spectral complexity is reduced.
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